Benzydamine for the topical treatment of vulvovaginitis in children and adolescents.
A study was undertaken in children and adolescents aged 4-18 years on the value of benzydamine vaginal douche in addition to chemotherapy for moderate to severe vulvovaginitis, including those also suffering from insulin-dependent diabetes mellitus (IDDM). It is considered that topical benzydamine gave beneficial results compared with the controls receiving chemotherapy alone and had in the IDDM patients a useful prophylactic effect.
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001591:Benzydamine / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D005260:Female; D006801:Humans; D011720:Pyrazoles / Q000627:therapeutic use*; D007507:Therapeutic Irrigation; D014848:Vulvovaginitis / Q000150:complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D011720:Pyrazoles; D001591:Benzydamine